New Biosimiliars Guidance - Has Anything Changed? Webinar

New Biosimiliars Guidance – Has Anything Changed? – Webinar

In this webinar, Bob Roth, M.D., Ph.D., Vice President & Worldwide Medical Director, The Weinberg Group, and Nick Fleischer, R.Ph., Ph.D., Vice President, Clinical Pharmacology & Biopharmaceutics, The Weinberg Group, help life science executives understand the market opportunity in pursuing biosimilars.